STOCK TITAN

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Mind Medicine (MindMed) Inc. plans to host a conference call on November 2, 2023, to provide a corporate update and review its Q3 2023 results.
Positive
  • Investors can gain insights into MindMed's performance and future prospects during the conference call.
Negative
  • No negative takes available.

NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, November 2, 2023, at 4:30 p.m. ET to provide a corporate update and review the Company’s results for the quarter ended September 30, 2023.

Individuals may participate in the live call via telephone by dialing (855) 327-6837 (domestic) or (631) 891-4304 (international). The webcast can be accessed live here on the Financials page in the Investors section of the MindMed website, https://mindmed.co/. The webcast will be archived on the Company’s website for at least 30 days after the conference call.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media & Investor Inquiries, please contact:



Maxim Jacobs, CFA

Vice President, Investor Relations and Corporate Communications

Mind Medicine (MindMed) Inc.

ir@mindmed.co

media@mindmed.co

Source: Mind Medicine (MindMed) Inc.

MindMed is hosting the conference call on Thursday, November 2, 2023.

Individuals can participate in the live call by dialing (855) 327-6837 (domestic) or (631) 891-4304 (international).

The webcast can be accessed live on the Financials page in the Investors section of the MindMed website, https://mindmed.co/.

Yes, the webcast will be archived on the Company's website for at least 30 days after the conference call.
Mind Medicine Inc

NASDAQ:MNMD

MNMD Rankings

MNMD Latest News

MNMD Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Vancouver

About MNMD

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.